Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain
Crossref DOI link: https://doi.org/10.1007/s12094-017-1784-1
Published Online: 2017-11-07
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ciruelos, E. http://orcid.org/0000-0002-2796-1042
Vidal, M.
Martínez de Dueñas, E.
Martínez-Jáñez, N.
Fernández, Y.
García-Sáenz, J. A.
Murillo, L.
Carabantes, F.
Beliera, A.
Fonseca, R.
Gavilá, J.
License valid from 2017-11-07